Dear UMB Community:

It is my pleasure to write to you today with good news! On Aug. 1, 2022, the University of Maryland School of Medicine (UMSOM) will have a new dean, Mark T. Gladwin, MD. Dr. Gladwin is a physician-scientist, clinician, educator, and academic leader, and I am confident that he will be an effective leader for UMSOM.

Dr. Gladwin currently serves as the Jack D. Myers Distinguished Professor and chair of the Department of Medicine at the University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center (UPMC). Department chair since 2014, he oversees more than 750 faculty and combined clinical and research revenues of about $300 million. He also serves as associate dean for physician-scientist mentoring and associate vice chancellor for science strategy, health sciences.

He previously served as chief of the pulmonary and vascular medicine branches and director of the functional genomics core of the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH). In 2008, he joined the University of Pittsburgh as a professor of medicine in the division of pulmonary, allergy, and critical care medicine, and director of the Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, a position he held until 2019. He currently serves as co-director of UPMC’s Heart and Vascular Institute.

Dr. Gladwin leads active basic and clinical research programs, directs a T32 training grant, and attends in the medical ICU. As the Department of Medicine chair, he also supported the development of a long list of research centers of excellence, including in aging, the microbiome, antibody therapeutics, hypertension, behavioral health, palliative care, and sickle cell research, which has been a focus of Dr. Gladwin’s research for more than 20 years.

He earned his bachelor’s and medical degrees from the University of Miami. He completed his internship and chief residency in internal medicine at the Oregon Health Sciences University in Portland, followed by a critical care medicine fellowship at NIH and a pulmonary fellowship at the University of Washington in Seattle. He is the co-author of the textbooks “Clinical Microbiology Made Ridiculously Simple” and “Critical Care and Hospitalist Medicine Made Ridiculously Simple.”

Throughout his career, Dr. Gladwin has been committed to promoting diversity, equity, and inclusion. In addition to creating a vice chair for diversity and inclusion position with significant financial resources, he has worked with his teams to develop programs that attract and retain accomplished underrepresented minority faculty, and he established an underrepresented minority advisory committee that worked to identify challenges and provide insight, expertise, and a forum for improvement. Under his leadership, the Department of Medicine has aggressively recruited, retained, and promoted fellows and faculty who are underrepresented in medicine, and recruited a diverse leadership team at the divisional and vice chair levels. Dr. Gladwin looks forward to continuing his commitment to diversity and inclusion at UMB.

I want to thank UMSOM Dean E. Albert Reece, MD, PhD, MBA, for his assistance with the search. His leadership, scholarship, and dedication set a very high standard for all who serve this University and our community. Dr. Reece will continue as dean until Dr. Gladwin’s arrival.

I also want to thank those who participated in our comprehensive national search, especially the search committee chaired by Claire M. Fraser, PhD, Dean’s Endowed Professor of Medicine and director of the Institute for Genome Sciences; co-chair Roger J. Ward, EdD, JD, MSL, MPA, provost, executive vice president, and dean of the Graduate School; and everyone else who met with the candidates and provided meaningful input and feedback about the candidates and the search process.

I know that you will join me in welcoming Dr. Gladwin to UMB.

Sincerely,

Bruce E. Jarrell, MD, FACS

President